Table 3.
Univariable analysis | Multivariable analysis1 | |||
---|---|---|---|---|
OR (95% CI) | P Value | OR (95% CI) | P Value | |
Age | 1.051 (1.012-1.091) | 0.010 | 1.040 (1.000-1.082) | 0.052 |
Sex (male) | 1.642 (1.046-2.575) | 0.031 | 1.509 (0.884-2.576) | 0.131 |
Education | 0.970 (0.919-1.024) | 0.270 | — | — |
Body mass index | 1.038 (0.970-1.111) | 0.280 | — | — |
Current smoking | 1.347 (0.695-2.610) | 0.378 | — | — |
Alcohol use | 1.690 (0.790-3.614) | 0.176 | — | — |
Hypertension | 2.157 (1.262-3.687) | 0.005 | 1.939 (1.060-3.548) | 0.032 |
SBP | 1.016 (1.003-1.029) | 0.014 | 1.010 (0.996-1.024) | 0.164 |
DBP | 1.014 (0.994-1.034) | 0.160 | — | — |
Duration of T2DM | 0.994 (0.968-1.021) | 0.656 | — | — |
HbA1c | 1.082 (0.924-1.028) | 0.329 | — | — |
Coronary heart disease | 0.836 (0.505-1.382) | 0.485 | — | — |
History of stroke | 2.872 (1.799-4.586) | < 0.001 | 2.234 (1.357-3.677) | 0.002 |
TC | 0.961 (0.790-1.686) | 0.689 | — | — |
HDL | 0.291 (0.119-0.711) | 0.007 | 0.514 (0.185-1.428) | 0.202 |
LDL | 0.931 (0.716-1.209) | 0.592 | — | — |
Uric acid | 1.000 (0.997-1.003) | 0.979 | — | — |
Serum tHcy | 1.017 (0.992-1.043) | 0.186 | — | — |
Medication | ||||
Antiplatelet Statin Insulin Metformin DPP-4 inhibitors GLP-1 receptor agonist |
0.737 (0.457-1.188) 0.853 (0.545-1.336) 1.389 (0.873-2.212) 0.614 (0.361-1.045) 1.167 (0.698-1.952) 1.321 (0.738-2.364) |
0.210 0.488 0.166 0.072 0.555 0.348 |
— — — 0.666 (0.373-1.187) — — |
— — — 0.168 — — |
TyG index | 1.582 (1.123-2.227) | 0.009 | 1.472 (1.003-2.160) | 0.048 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; T2DM, type 2 diabetes mellitus; TC, total cholesterol; HDL, high density lipoprotein; LDL, low density lipoprotein; tHcy, total homocysteine; TyG, triglyceride glucose; CSVD, cerebral small vessel disease.
1Adjusted with P < 0.10 in the univariable analysis (age, sex, hypertension, SBP, history of stroke, HDL, metformin usage and TyG index).